Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...
Q2 2025 Earnings Call Transcript January 30, 2025 ResMed Inc. beats earnings expectations. Reported EPS is $2.43, expectations were $2.32. Operator: Welcome to the Q2 Fiscal Year 2025 ResMed Earnings ...
Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...
CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, breathing health, and residential care software portfolios. Device sales, including AirSense 10 and ...
The note reveals that Goldman has initiated coverage with a buy rating and $48.90 price target on ResMed's shares. Based on ...
Hosted on MSN15d
Goldman Sachs tips ResMed shares to rocket 30% to a record highResMed Inc. (ASX: RMD) shares have been on fire over the past 12 months. During this time, the sleep disorder treatment company's shares have rallied 44% higher. But if you thought the gains were ...
It is similar in some ways to other therapy modes, including CPAP and bilevel ... by Philips Respironics and ResMed, respectively. These devices—and the associated masks, tubing, and other needed ...
How often should you replace your CPAP supplies may be determined in part by your insurance ... has two integrated filters that can be replaced with this same frequency. The ResMed AirSense machines ...
ResMed stock is down today, even though the maker of CPAPs and other respiratory treatment devices had Street-beating Q2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback